Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL6750374

CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)([O-])c1ccc(O)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ KCNH2 Q12809 2/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NR1I2 O75469 1/20 0.45
▸ ESR1 P03372 4/20 0.43
▸ ENPP2 Q13822 1/20 0.42
▸ HSD17B3 P37058 7/20 0.42
▸ ADRA2A P08913 2/20 0.42
▸ ADORA3 P0DMS8 2/20 0.42
▸ TACR2 P21452 2/20 0.42
▸ SLC6A2 P23975 2/20 0.42
▸ SLC6A4 P31645 2/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ PTGS2 P35354 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrapropylammonium SCHEMBL5031704 0.89 ENPP2 (0.45) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL332036 0.84 KCNH2 (0.48) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL157620 0.84 LMNA (0.61) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL29130238 0.83 ESR1 (0.47) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL9450288 0.83 LMNA (0.60) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL19019699 0.83 GAA (0.47) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL5693988 0.83 KCNH2 (0.64) LMNAKCNH2HIF1ACYP2D6CYP2C9
Tetrabuthylammonium SCHEMBL11739846 0.82 KCNH2 (0.44) LMNAKCNH2HIF1ACYP2D6CYP2C9
SCHEMBL330757 0.81 HTT (0.52) LMNAKCNH2HIF1ACYP2D6CYP2C9
SCHEMBL9619329 0.81 KCNH2 (0.66) LMNAKCNH2HIF1ACYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706657-B2 USING COORDINATION CATALYST INSTITUT FRANCAIS DU PETROLE (FR) 2004-03-16 — — US disclosed
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2003-06-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins NOTUM, PHOSPHO1, ADH5 LMNA 4516/4885KCNH2 3670/4885HIF1A 4015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback